BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34804859)

  • 21. Evaluation of Strip Meniscometry and Association with Clinical and Demographic Variables in a Community Eye Study (in Bangladesh).
    Rashid MAKM; Thia ZZ; Teo CHY; Mamun S; Ong HS; Tong L
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33092288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms.
    Bhargava R; Chandra M; Bansal U; Singh D; Ranjan S; Sharma S
    Curr Eye Res; 2016 Oct; 41(10):1274-1280. PubMed ID: 27050028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, sham-controlled trial of intraductal meibomian gland probing with or without topical antibiotic/steroid for obstructive meibomian gland dysfunction.
    Kheirkhah A; Kobashi H; Girgis J; Jamali A; Ciolino JB; Hamrah P
    Ocul Surf; 2020 Oct; 18(4):852-856. PubMed ID: 32882429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction.
    Kim HY; Lee JE; Oh HN; Song JW; Han SY; Lee JS
    Int J Ophthalmol; 2018; 11(4):593-600. PubMed ID: 29675376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of dry eye after cataract surgery in MGD patients.
    Qiu JJ; Sun T; Fu SH; Yu YF; You ZP; Zhang Q; Liu F; Huang JQ; Wang ZH
    Int Ophthalmol; 2020 May; 40(5):1277-1284. PubMed ID: 31981000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meibomian gland dysfunction is the primary determinant of dry eye symptoms: Analysis of 2346 patients.
    Teo CHY; Ong HS; Liu YC; Tong L
    Ocul Surf; 2020 Oct; 18(4):604-612. PubMed ID: 32682082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes.
    Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP
    Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period.
    Ge J; Liu N; Wang X; Du Y; Wang C; Li Z; Li J; Wang L
    BMC Ophthalmol; 2020 Mar; 20(1):111. PubMed ID: 32188437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction.
    Xue AL; Wang MTM; Ormonde SE; Craig JP
    Ocul Surf; 2020 Apr; 18(2):286-297. PubMed ID: 32007523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye.
    Vu CHV; Kawashima M; Yamada M; Suwaki K; Uchino M; Shigeyasu C; Hiratsuka Y; Yokoi N; Tsubota K;
    Ophthalmology; 2018 Aug; 125(8):1181-1188. PubMed ID: 29459039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vivo confocal microscopy evaluation of meibomian glands in meibomian gland dysfunction patients].
    Liang QF; Gao C; Liang H; Du XH; Wang NL; Labbe A
    Zhonghua Yan Ke Za Zhi; 2016 Sep; 52(9):649-56. PubMed ID: 27647244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome.
    Wang Y; Qin Q; Liu B; Fu Y; Lin L; Huang X; Jin X
    Front Med (Lausanne); 2019; 6():291. PubMed ID: 31921869
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye.
    Bhargava R; Kumar P; Phogat H; Kaur A; Kumar M
    Cont Lens Anterior Eye; 2015 Jun; 38(3):206-10. PubMed ID: 25697893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction.
    Yurttaser Ocak S; Karakus S; Ocak OB; Cakir A; Bolukbasi S; Erden B; Bas E; Elcioglu M
    Int Ophthalmol; 2020 May; 40(5):1135-1141. PubMed ID: 31916061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the Tear Meniscus by Strip Meniscometry and Keratograph in Patients With Dry Eye Disease According to the Presence of Meibomian Gland Dysfunction.
    Lee KW; Kim JY; Chin HS; Seo KY; Kim TI; Jung JW
    Cornea; 2017 Feb; 36(2):189-195. PubMed ID: 28060066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction.
    Dell SJ; Gaster RN; Barbarino SC; Cunningham DN
    Clin Ophthalmol; 2017; 11():817-827. PubMed ID: 28496300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of intense pulsed light therapy in the treatment of Meibomian gland dysfunction-related severe dry eye].
    Egri S; Van Hollebecke I; Guindolet D; Manenti C; Rougier H; Gabison É; Cochereau I; Doan S
    J Fr Ophtalmol; 2021 Feb; 44(2):169-175. PubMed ID: 33358077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the expression of matrix metalloproteinase-9 after intense pulsed light therapy combined with meibomian gland expression in moderate and severe meibomian gland dysfunction.
    Lee H; Han YE; Park SY; Lee JH; Chung HS; Moon SY; Kim JY; Tchah H
    Cont Lens Anterior Eye; 2021 Jun; 44(3):101339. PubMed ID: 32948417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the levels of prostaglandin E2 in tears and severity of dry eye.
    Lekhanont K; Sathianvichitr K; Pisitpayat P; Anothaisintawee T; Soontrapa K; Udomsubpayakul U
    Int J Ophthalmol; 2019; 12(7):1127-1133. PubMed ID: 31341803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.